Calidi Biotherapeutics, Inc.
CLDI- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.
Other share classesCLDWW
13F holders, Q3 2022
Institutional positions in Calidi Biotherapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −21 vs. Q2 2022
- Shares held
- 3.72M
- −18.0M (−82.9%) vs. Q2 2022
- Total value
- $36.1M
- −$178.8M (−83.2%) vs. Q2 2022
- New holders
- 9
- 0 more added
- Sold out
- 30
- 7 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLDI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $89.3K |
| Q1 2026 | 28 | $478.8K |
| Q4 2025 | 27 | $524.7K |
| Q3 2025 | 22 | $353.6K |
| Q2 2025 | 35 | $656.8K |
| Q1 2025 | 36 | $3.09M |
| Q4 2024 | 33 | $1.27M |
| Q3 2024 | 20 | $363.4K |
| Q2 2024 | 32 | $523.2K |
| Q1 2024 | 31 | $1.56M |
| Q4 2023 | 25 | $3.29M |
| Q3 2023 | 13 | $3.54M |
| Q2 2023 | 25 | $40.6M |
| Q1 2023 | 27 | $45.8M |
| Q4 2022 | 25 | $39.6M |
| Q3 2022 | 21 | $36.1M |
| Q2 2022 | 42 | $214.8M |
| Q1 2022 | 40 | $202.4M |
| Q4 2021 | 27 | $184.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Calidi Biotherapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Driehaus Capital Management LLC | 1,000,000 | $9.85M | 0.15% | −500,000−33.3% | Reduced |
| Polar Asset Management Partners Inc. | 449,000 | $4.42M | 0.06% | −1,821,673−80.2% | Reduced |
| Woodline Partners LP | 400,000 | $3.94M | 0.06% | −1,580,000−79.8% | Reduced |
| Vivaldi Asset Management, LLC | 400,000 | $3.94M | 0.19% | +400,000 | New |
| 683 Capital Management, LLC | 300,000 | $2.96M | 0.24% | −900,000−75.0% | Reduced |
| Shaolin Capital Management LLC | 200,000 | $1.97M | 0.05% | −1,200,000−85.7% | Reduced |
| Spartan Fund Management Inc. | 150,000 | $1.48M | 0.45% | +150,000 | New |
| Logan Stone Capital, LLC | 149,600 | $1.47M | 0.97% | +149,600 | New |
| Highbridge Capital Management LLC | 125,000 | $1.23M | 0.02% | 00.0% | Unchanged |
| Kim, LLC | 100,000 | $985.0K | 0.05% | +100,000 | New |
| Citadel Advisors LLC | 93,844 | $924.0K | 0.00% | +93,844 | New |
| Cowen and Company, LLC | 90,624 | $893.0K | 0.09% | +90,624 | New |
| Virtu Financial LLC | 79,569 | $784.0K | 0.07% | +79,569 | New |
| CNH Partners LLC | 40,584 | $400.0K | 0.01% | 00.0% | Unchanged |
| Ergoteles LLC | 32,200 | $317.0K | 0.01% | +32,200 | New |
| Wolverine Asset Management LLC | 17,943 | $176.0K | 0.00% | −309,443−94.5% | Reduced |
| Old Mission Capital LLC | 12,704 | $125.0K | 0.01% | −5,961−31.9% | Reduced |
| HRT Financial LP | 10,918 | $107.0K | 0.00% | +10,918 | New |
| Magnetar Financial LLC | 63,132 | $79.0K | 0.00% | 00.0% | Unchanged |
| Dark Forest Capital Management LP | 2,000 | $20.0K | 0.00% | 00.0% | Unchanged |
| Clear Street LLC | 100 | $1.00K | 0.00% | 00.0% | Unchanged |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −1,871,272−100.0% | Sold out |
| Apollo Management Holdings, L.P. | 0 | $0 | 0.00% | −1,188,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −1,062,226−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −1,046,101−100.0% | Sold out |
| Governors Lane LP | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Aristeia Capital LLC | 0 | $0 | 0.00% | −990,000−100.0% | Sold out |
| Periscope Capital Inc. | 0 | $0 | 0.00% | −964,081−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −820,025−100.0% | Sold out |
| Sculptor Capital LP | 0 | $0 | 0.00% | −764,600−100.0% | Sold out |
| Saba Capital Management, L.P. | 0 | $0 | 0.00% | −621,500−100.0% | Sold out |
| Radcliffe Capital Management, L.P. | 0 | $0 | 0.00% | −400,580−100.0% | Sold out |
| Oaktree Capital Management LPSuperinvestorOaktree Capital | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −254,044−100.0% | Sold out |
| Berkley W R Corp | 0 | $0 | 0.00% | −235,621−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −199,996−100.0% | Sold out |
| Rpo LLC | 0 | $0 | 0.00% | −173,483−100.0% | Sold out |
| Blackstone Group Inc. | 0 | $0 | 0.00% | −170,842−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −126,349−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −86,493−100.0% | Sold out |
| Linden Advisors LP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Segantii Capital Management Ltd | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Elequin Capital LP | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Kohlberg Kravis Roberts & Co. L.P. | 0 | $0 | 0.00% | −35,317−100.0% | Sold out |
| Arena Investors LP | 0 | $0 | 0.00% | −35,123−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −32,380−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −27,520−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,588−100.0% | Sold out |
| Cohen & Co Financial Management, LLC | 0 | $0 | 0.00% | −31,767−100.0% | Sold out |